Naturhouse Health (XMAD:NTH) Piotroski F-Score: 7 (As of Jun. 24, 2026) — 17% Above Median


XMAD:NTH Naturhouse Health SA XMAD:NTH
81 GF Score
Price €2.53
GF Value €1.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Naturhouse Health Piotroski F-Score?

Naturhouse Health XMAD:NTH -0.78% 81 Piotroski F-Score is 7 as of Jun. 24, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,912 Consumer Packaged Goods companies, Naturhouse Health ranks better than 88.6% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Naturhouse Health has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Naturhouse Health's Piotroski F-Score or its related term are showing as below:

XMAD:NTH' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 7

During the past 13 years, the highest Piotroski F-Score of Naturhouse Health was 8. The lowest was 3. And the median was 6.

Naturhouse Health  (XMAD:NTH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Naturhouse Health Piotroski F-Score Related Terms


Naturhouse Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Naturhouse Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturhouse Health Piotroski F-Score Chart

Naturhouse Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 3.00 8.00 5.00 7.00

Naturhouse Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.00 0.00 5.00 0.00 7.00

XMAD:NTH vs KHC, GIS, JBS: Piotroski F-Score Comparison

For the Packaged Foods subindustry, Naturhouse Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturhouse Health Piotroski F-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Naturhouse Health's Piotroski F-Score falls into.


XMAD:NTH
81GF Score
Naturhouse Health SA XMAD:NTH
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Net Income was €10.09 Mil.
Cash Flow from Operations was €12.15 Mil.
Revenue was €47.63 Mil.
Gross Profit was €34.27 Mil.
Average Total Assets from the begining of this year (Dec24)
to the end of this year (Dec25) was (42.593 + 33.433) / 2 = €38.013 Mil.
Total Assets at the begining of this year (Dec24) was €42.59 Mil.
Long-Term Debt & Capital Lease Obligation was €1.90 Mil.
Total Current Assets was €19.59 Mil.
Total Current Liabilities was €11.88 Mil.
Net Income was €9.86 Mil.

Revenue was €49.43 Mil.
Gross Profit was €35.46 Mil.
Average Total Assets from the begining of last year (Dec23)
to the end of last year (Dec24) was (48.846 + 42.593) / 2 = €45.7195 Mil.
Total Assets at the begining of last year (Dec23) was €48.85 Mil.
Long-Term Debt & Capital Lease Obligation was €2.16 Mil.
Total Current Assets was €28.18 Mil.
Total Current Liabilities was €6.46 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Naturhouse Health's current Net Income (TTM) was 10.09. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Naturhouse Health's current Cash Flow from Operations (TTM) was 12.15. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec24)
=10.094/42.593
=0.2369873

ROA (Last Year)=Net Income/Total Assets (Dec23)
=9.863/48.846
=0.20192032

Naturhouse Health's return on assets of this year was 0.2369873. Naturhouse Health's return on assets of last year was 0.20192032. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Naturhouse Health's current Net Income (TTM) was 10.09. Naturhouse Health's current Cash Flow from Operations (TTM) was 12.15. ==> 12.15 > 10.09 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec24 to Dec25
=1.904/38.013
=0.05008813

Gearing (Last Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=2.161/45.7195
=0.04726648

Naturhouse Health's gearing of this year was 0.05008813. Naturhouse Health's gearing of last year was 0.04726648. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec25)=Total Current Assets/Total Current Liabilities
=19.59/11.88
=1.6489899

Current Ratio (Last Year: Dec24)=Total Current Assets/Total Current Liabilities
=28.177/6.464
=4.35906559

Naturhouse Health's current ratio of this year was 1.6489899. Naturhouse Health's current ratio of last year was 4.35906559. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Naturhouse Health's number of shares in issue this year was 59.949. Naturhouse Health's number of shares in issue last year was 59.949. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=34.271/47.629
=0.71954062

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=35.463/49.425
=0.71751138

Naturhouse Health's gross margin of this year was 0.71954062. Naturhouse Health's gross margin of last year was 0.71751138. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec24)
=47.629/42.593
=1.11823539

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec23)
=49.425/48.846
=1.01185358

Naturhouse Health's asset turnover of this year was 1.11823539. Naturhouse Health's asset turnover of last year was 1.01185358. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+0+1+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Naturhouse Health has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Naturhouse Health (XMAD:NTH) has a Piotroski F-Score of 7 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Naturhouse Health and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Naturhouse Health's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Naturhouse Health ranks #218 out of 1912 companies in the Consumer Packaged Goods industry, placing it in the top 11.4%.
Is Naturhouse Health's Piotroski F-Score too high?
Naturhouse Health's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Naturhouse Health's value of 7 is 40% above this industry median. Based on the distribution chart, Naturhouse Health ranks #218 out of 1912 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Piotroski F-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #218 out of 1912 companies for Piotroski F-Score. This places Naturhouse Health in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Naturhouse Health's value of 7 is 40% above this benchmark. Historically, Naturhouse Health's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,912 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.53 — trading 56.2% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Consumer Packaged Goods industry median of 5.00. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Piotroski F-Score is 7 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?

Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued. The current stock price of €2.53 is trading 56.2% above its estimated GF Value™ of €1.62. GuruFocus considers Naturhouse Health to be Significantly Overvalued.

Key valuation signals for XMAD:NTH:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: €1.62 vs. price of €2.53 (56.2% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 40% above the Consumer Packaged Goods median (#218 of 1912)

No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturhouse Health Business Description

Other Exchanges 0R9G:UK2NH:Germany
Address Calle Claudio Coello, 91, 4º Planta, Madrid, ESP, 28006
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score

Get the complete analysis for XMAD:NTH

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.53
Price
€1.62
GF Value